Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.54 Billion USD | 41.65% |
| 2022 | 1.09 Billion USD | 9.77% |
| 2021 | 993 Million USD | -9.23% |
| 2020 | 1.09 Billion USD | -1.17% |
| 2019 | 1.1 Billion USD | 18.52% |
| 2018 | 934 Million USD | -10.88% |
| 2017 | 1.04 Billion USD | -1.23% |
| 2016 | 1.06 Billion USD | -15.57% |
| 2015 | 1.25 Billion USD | 32.19% |
| 2014 | 950.6 Million USD | 7.66% |
| 2013 | 882.96 Million USD | 66.2% |
| 2012 | 531.25 Million USD | 49.56% |
| 2011 | 355.21 Million USD | 54.72% |
| 2010 | 229.58 Million USD | 177.36% |
| 2009 | 82.77 Million USD | 38.97% |
| 2008 | 59.56 Million USD | -26.24% |
| 2007 | 80.74 Million USD | 2.5% |
| 2006 | 78.77 Million USD | -11.95% |
| 2005 | 89.47 Million USD | -18.77% |
| 2004 | 110.15 Million USD | 31.05% |
| 2003 | 84.05 Million USD | 58.46% |
| 2002 | 53.04 Million USD | 37.76% |
| 2001 | 38.5 Million USD | 59.72% |
| 2000 | 24.1 Million USD | 89.83% |
| 1999 | 12.7 Million USD | 20.95% |
| 1998 | 10.5 Million USD | -36.75% |
| 1997 | 16.6 Million USD | 104.94% |
| 1996 | 8.1 Million USD | 107.69% |
| 1995 | 3.9 Million USD | 680.0% |
| 1994 | 500 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.65 Billion USD | 2.68% |
| 2024 Q2 | 1.61 Billion USD | -1.38% |
| 2024 Q1 | 1.63 Billion USD | 5.85% |
| 2023 Q3 | 1.27 Billion USD | -22.59% |
| 2023 FY | 1.54 Billion USD | 41.65% |
| 2023 Q4 | 1.54 Billion USD | 21.38% |
| 2023 Q2 | 1.64 Billion USD | 34.47% |
| 2023 Q1 | 1.22 Billion USD | 12.11% |
| 2022 Q4 | 1.09 Billion USD | 3.22% |
| 2022 FY | 1.09 Billion USD | 9.77% |
| 2022 Q1 | 1.04 Billion USD | 5.24% |
| 2022 Q2 | 1.07 Billion USD | 2.68% |
| 2022 Q3 | 1.05 Billion USD | -1.58% |
| 2021 Q3 | 1.05 Billion USD | -2.58% |
| 2021 Q1 | 1.07 Billion USD | -1.65% |
| 2021 Q4 | 993 Million USD | -6.14% |
| 2021 Q2 | 1.08 Billion USD | 0.93% |
| 2021 FY | 993 Million USD | -9.23% |
| 2020 Q4 | 1.09 Billion USD | -10.62% |
| 2020 Q3 | 1.22 Billion USD | -0.16% |
| 2020 FY | 1.09 Billion USD | -1.17% |
| 2020 Q1 | 1.12 Billion USD | 1.54% |
| 2020 Q2 | 1.22 Billion USD | 9.07% |
| 2019 Q1 | 1.01 Billion USD | 8.35% |
| 2019 FY | 1.1 Billion USD | 18.52% |
| 2019 Q4 | 1.1 Billion USD | 0.64% |
| 2019 Q3 | 1.1 Billion USD | 3.77% |
| 2019 Q2 | 1.06 Billion USD | 4.74% |
| 2018 Q4 | 934 Million USD | -3.81% |
| 2018 FY | 934 Million USD | -10.88% |
| 2018 Q3 | 971 Million USD | -2.22% |
| 2018 Q2 | 993 Million USD | -4.7% |
| 2018 Q1 | 1.04 Billion USD | -0.57% |
| 2017 Q4 | 1.04 Billion USD | -2.15% |
| 2017 Q3 | 1.07 Billion USD | -1.2% |
| 2017 Q1 | 1.11 Billion USD | 4.71% |
| 2017 FY | 1.04 Billion USD | -1.23% |
| 2017 Q2 | 1.08 Billion USD | -2.43% |
| 2016 Q2 | 1.33 Billion USD | 1.25% |
| 2016 Q1 | 1.32 Billion USD | 5.06% |
| 2016 FY | 1.06 Billion USD | -15.57% |
| 2016 Q3 | 1.3 Billion USD | -2.74% |
| 2016 Q4 | 1.06 Billion USD | -18.39% |
| 2015 Q4 | 1.25 Billion USD | 4.79% |
| 2015 Q2 | 1.22 Billion USD | 23.09% |
| 2015 FY | 1.25 Billion USD | 32.19% |
| 2015 Q1 | 998.9 Million USD | 5.08% |
| 2015 Q3 | 1.19 Billion USD | -2.46% |
| 2014 FY | 950.6 Million USD | 7.66% |
| 2014 Q2 | 942.5 Million USD | -1.14% |
| 2014 Q3 | 932.7 Million USD | -1.04% |
| 2014 Q4 | 950.6 Million USD | 1.92% |
| 2014 Q1 | 953.4 Million USD | 7.98% |
| 2013 Q3 | 1.07 Billion USD | 116.49% |
| 2013 Q4 | 882.96 Million USD | -17.95% |
| 2013 Q2 | 497.05 Million USD | -2.48% |
| 2013 Q1 | 509.67 Million USD | -4.06% |
| 2013 FY | 882.96 Million USD | 66.2% |
| 2012 FY | 531.25 Million USD | 49.56% |
| 2012 Q1 | 373.52 Million USD | 5.16% |
| 2012 Q2 | 388.72 Million USD | 4.07% |
| 2012 Q3 | 418.25 Million USD | 7.59% |
| 2012 Q4 | 531.25 Million USD | 27.02% |
| 2011 FY | 355.21 Million USD | 54.72% |
| 2011 Q2 | 259.78 Million USD | -2.39% |
| 2011 Q3 | 259.64 Million USD | -0.05% |
| 2011 Q4 | 355.21 Million USD | 36.81% |
| 2011 Q1 | 266.13 Million USD | 15.92% |
| 2010 Q1 | 97.52 Million USD | 17.82% |
| 2010 FY | 229.58 Million USD | 177.36% |
| 2010 Q3 | 295.27 Million USD | 235.03% |
| 2010 Q4 | 229.58 Million USD | -22.25% |
| 2010 Q2 | 88.13 Million USD | -9.63% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | -100.0% |
| 2009 Q4 | 82.77 Million USD | 0.0% |
| 2009 FY | 82.77 Million USD | 38.97% |
| 2009 Q1 | 60.17 Million USD | 1.03% |
| 2008 FY | 59.56 Million USD | -26.24% |
| 2008 Q4 | 59.56 Million USD | -15.1% |
| 2008 Q3 | 70.15 Million USD | 0.45% |
| 2008 Q1 | 67.42 Million USD | -16.49% |
| 2008 Q2 | 69.83 Million USD | 3.57% |
| 2007 Q2 | 86.5 Million USD | 8.39% |
| 2007 FY | 80.74 Million USD | 2.5% |
| 2007 Q3 | 90.39 Million USD | 4.5% |
| 2007 Q1 | 79.8 Million USD | 1.3% |
| 2007 Q4 | 80.74 Million USD | -10.68% |
| 2006 Q2 | 87.65 Million USD | -4.37% |
| 2006 FY | 78.77 Million USD | -11.95% |
| 2006 Q1 | 91.65 Million USD | 2.44% |
| 2006 Q3 | 81.25 Million USD | -7.3% |
| 2006 Q4 | 78.77 Million USD | -3.05% |
| 2005 Q3 | 88.1 Million USD | -12.94% |
| 2005 Q1 | 118.83 Million USD | 7.88% |
| 2005 Q2 | 101.19 Million USD | -14.84% |
| 2005 Q4 | 89.47 Million USD | 1.55% |
| 2005 FY | 89.47 Million USD | -18.77% |
| 2004 Q4 | 110.15 Million USD | 12.5% |
| 2004 Q2 | 94.85 Million USD | 6.68% |
| 2004 Q1 | 88.92 Million USD | 5.79% |
| 2004 Q3 | 97.91 Million USD | 3.23% |
| 2004 FY | 110.15 Million USD | 31.05% |
| 2003 Q4 | 84.05 Million USD | 1.81% |
| 2003 Q3 | 82.56 Million USD | 6.62% |
| 2003 Q2 | 77.43 Million USD | 18.27% |
| 2003 Q1 | 65.47 Million USD | 23.43% |
| 2003 FY | 84.05 Million USD | 58.46% |
| 2002 Q4 | 53.04 Million USD | 22.62% |
| 2002 Q1 | 42.77 Million USD | 11.1% |
| 2002 Q3 | 43.26 Million USD | -11.2% |
| 2002 Q2 | 48.71 Million USD | 13.88% |
| 2002 FY | 53.04 Million USD | 37.76% |
| 2001 Q4 | 38.5 Million USD | -5.8% |
| 2001 FY | 38.5 Million USD | 59.72% |
| 2001 Q1 | 31.84 Million USD | 32.09% |
| 2001 Q2 | 39.15 Million USD | 22.96% |
| 2001 Q3 | 40.87 Million USD | 4.4% |
| 2000 Q2 | 23.89 Million USD | 31.78% |
| 2000 FY | 24.1 Million USD | 89.83% |
| 2000 Q1 | 18.13 Million USD | 42.76% |
| 2000 Q4 | 24.1 Million USD | 2.44% |
| 2000 Q3 | 23.53 Million USD | -1.5% |
| 1999 Q2 | 15.2 Million USD | 10.14% |
| 1999 Q3 | 14.1 Million USD | -7.24% |
| 1999 Q4 | 12.7 Million USD | -9.93% |
| 1999 FY | 12.7 Million USD | 20.95% |
| 1999 Q1 | 13.8 Million USD | 31.43% |
| 1998 Q1 | 19 Million USD | 14.46% |
| 1998 Q3 | 18 Million USD | -2.17% |
| 1998 Q2 | 18.4 Million USD | -3.16% |
| 1998 FY | 10.5 Million USD | -36.75% |
| 1998 Q4 | 10.5 Million USD | -41.67% |
| 1997 Q1 | 9.7 Million USD | 19.75% |
| 1997 Q4 | 16.6 Million USD | 4.4% |
| 1997 Q3 | 15.9 Million USD | 76.67% |
| 1997 Q2 | 9 Million USD | -7.22% |
| 1997 FY | 16.6 Million USD | 104.94% |
| 1996 Q2 | 7.3 Million USD | 37.74% |
| 1996 Q3 | 9.8 Million USD | 34.25% |
| 1996 Q4 | 8.1 Million USD | -17.35% |
| 1996 Q1 | 5.3 Million USD | 35.9% |
| 1996 FY | 8.1 Million USD | 107.69% |
| 1995 Q4 | 3.9 Million USD | 1.02% |
| 1995 FY | 3.9 Million USD | 680.0% |
| 1995 Q3 | 3.86 Million USD | 0.08% |
| 1995 Q1 | 100 Thousand USD | -80.0% |
| 1995 Q2 | 3.85 Million USD | 3757.69% |
| 1994 Q4 | 500 Thousand USD | 0.0% |
| 1994 FY | 500 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 581.38 Million USD | -165.573% |
| Catalent, Inc. | 574 Million USD | -168.99% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -369.444% |
| Elanco Animal Health Incorporated | 1.73 Billion USD | 11.009% |
| Perrigo Company plc | 1.14 Billion USD | -35.332% |
| Teva Pharmaceutical Industries Limited | 4.02 Billion USD | 61.602% |
| Zoetis Inc. | 2.56 Billion USD | 39.782% |